These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9466481)

  • 21. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.
    Estey E; Thall P; Andreeff M; Beran M; Kantarjian H; O'Brien S; Escudier S; Robertson LE; Koller C; Kornblau S
    J Clin Oncol; 1994 Apr; 12(4):671-8. PubMed ID: 7512125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of hematopoietic growth factors in the treatment of acute myelogenous leukemia.
    Ganser A; Heil G
    Curr Opin Hematol; 1997 May; 4(3):191-5. PubMed ID: 9209835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum during induction treatment of acute leukaemia.
    Sallerfors B; Olofsson T
    Br J Haematol; 1991 Jul; 78(3):343-51. PubMed ID: 1714757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute myeloid leukemia with cytokines: effect on duration of neutropenia and response to infections.
    Rowe JM
    Clin Infect Dis; 1998 Jun; 26(6):1290-4. PubMed ID: 9636848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factor.
    Kalaycio M; Pohlman B; Elson P; Lichtin A; Hussein M; Tripp B; Andresen S
    Am J Clin Oncol; 2001 Feb; 24(1):58-63. PubMed ID: 11232951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
    Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro growth response to G-CSF and GM-CSF by bone marrow cells of patients with acute myeloid leukemia.
    Jinnai I
    Leuk Res; 1990; 14(3):227-40. PubMed ID: 1690827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
    Ottmann OG; Bug G; Krauter J
    Semin Hematol; 2007 Jul; 44(3):183-92. PubMed ID: 17631182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of colony-stimulating factors in acute leukemia.
    Holdsworth MT; Mathew P
    Ann Pharmacother; 2001 Jan; 35(1):92-108. PubMed ID: 11197591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY; Xu B; Sun J; Yang Y; Niu JN
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth factor priming in therapy of acute myelogenous leukemia.
    Becker PS
    Curr Hematol Rep; 2004 Nov; 3(6):413-8. PubMed ID: 15496274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1 and interleukin-2 control granulocyte- and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia.
    Cozzolino F; Torcia M; Bettoni S; Aldinucci D; Burgio VL; Petti MC; Rubartelli A; Barbui T; Rambaldi A
    Int J Cancer; 1990 Nov; 46(5):902-7. PubMed ID: 1699903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte-macrophage colony stimulating factor (GM-CSF) in the treatment of hematological malignancies.
    Löwenberg B; de Greef GE; Wielenga JJ
    Anticancer Drugs; 1993 May; 4 Suppl 1():17-20. PubMed ID: 8347852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic growth factor (G-CSF or GM-CSF) after salvage chemotherapy in refractory or relapsed adult de novo acute leukemia.
    Martino R; Brunet S; Sureda A; Guàrdia R; Aventiín A; Soler J; Altés A; Domingo-Albós A
    Leuk Lymphoma; 1996 Jan; 20(3-4):321-6. PubMed ID: 8624474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of GM-CSF in the treatment of acute myeloid leukemia.
    Büchner T; Hiddemann W; Wörmann B; Rottmann R; Maschmeyer G; Ludwig WD; Zühlsdorf M; Buntkirchen K; Sander A; Aswald J
    Leuk Lymphoma; 1993; 11 Suppl 2():21-4. PubMed ID: 8124228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte-macrophage colony stimulating factor (GM-CSF) priming in the treatment of elderly patients with acute myelogenous leukemia.
    Frenette PS; Desforges JF; Schenkein DP; Rabson A; Slapack CA; Miller KB
    Am J Hematol; 1995 May; 49(1):48-55. PubMed ID: 7741138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of cytosine arabinoside cytotoxicity by granulocyte/macrophage colony-stimulating factor and granulocyte colony-stimulating factor in a human myeloblastic leukemia cell line.
    Takauji R; Tohyama K; Ueda T; Nakamura T
    Jpn J Cancer Res; 1993 Apr; 84(4):445-50. PubMed ID: 7685751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum TNF-alpha, gamma-INF, G-CSF and GM-CSF levels in neutropenic children with acute leukemia treated with short-course, high-dose methylprednisolone.
    Tuncer AM; Hiçsönmez G; Gümrük F; Sayli T; Güler E; Cetin M; Okur H
    Leuk Res; 1996 Mar; 20(3):265-9. PubMed ID: 8637222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma.
    Lehrnbecher T; Creutzig U
    Expert Rev Hematol; 2009 Apr; 2(2):159-72. PubMed ID: 21083449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.